The main objective of the present project is to study the effect of immunosuppressant agents used in clinical practice in liver transplantation on apoptosis in monoculture of isolated human hepatocytes, human hepatic stellate cells (HSCs) and in co-culture of human primary hepatocytes and HSCs
Other specific objectives
•Ob 1: To study the apoptosis associated gene expression profile using defined genes arrays in monoculture of human hepatocytes, monoculture of HSCs and co-culture of hepatocytes and HSCs after treatment of cultures with various immunosuppression agents
•Ob 2: To study the apoptosis associated gene expression profile using defined genes arrays in monoculture of human hepatocytes, monoculture of HSCs and co-culture according to CYP3A5 genotypes
•Ob 3: To propose a patient profile that is more prone to fibrosis development following LT according to in vitro studies
•Ob 4: To propose a certain medication or combination of immunosuppressants that can be safely used on long term without fibrosis development as a translational approach of personalized medicine
Methodology
•Hepatocyte and hepatic stellate cells isolation protocol
•DNA extraction
•RNA extraction and quantitative gene expression analysis
•Apoptosis assessment
•To achieve our objectives, we will use the infrastructure and logistics of Center of Excellence in Translational Medicine (CEMT), the new research Platform of Fundeni Clinical Institute. Please check the following link
http://erris.gov.ro/CENTER-OF-EXCELLENCE-IN-TRANto see the existent facility where the whole research will be conducted
Work plan (24 months)
•Stage I: Set-up of the experimental protocol
•Stage II: Development of human hepatocytes and hepatic stellate cells 2D and 3D culture systems according to the proposed protocols and apoptosis study
•Stage III: Statistical analysis of data and summary of results